What happened

In January 2026, the federal government temporarily canceled billions of dollars in grants that fund addiction treatment, mental health services, and overdose prevention. The funding—largely administered through SAMHSA—supports services such as medications for opioid use disorder (MOUD), harm reduction, crisis response, prevention programs, and peer recovery support.

Within days, the funding was restored. Agencies notified grantees that programs could continue as approved.

A new Millennium Health Signals Alert reveals compelling evidence that illicit stimulant use (cocaine and methamphetamine) is rising sharply across the United States, marking a concerning shift in substance use patterns and signaling critical implications for clinical care, public health strategy, and addiction treatment systems.

On December 1, 2025, the SUPPORT for Patients and Communities Reauthorization Act of 2025 was signed into law, extending critical federal substance use disorder (SUD) prevention, treatment, and recovery programs through fiscal year 2030. This bipartisan legislative achievement, passed overwhelmingly in the House and by unanimous consent in the Senate, reaffirms Congress’s commitment to combating the opioid and broader SUD crisis that continues to devastate communities nationwide.

CNN’s Chief Medical Correspondent joins Dr. Eric Garland, Dan Kruger discuss redefining pain management and recovery at April 6-9 event in Nashville.

MALVERN, Pa. (November 12, 2025) — Rx Summit will deliver its most advanced clinical education program yet at its 15th anniversary meeting in 2026, featuring six new sessions co-developed with the American Psychological Association’s Division 50 (APA Division 50), Society of Addiction Psychology (SoAP).